2.90
+0.6(+26.09%)
Currency In USD
| Previous Close | 2.3 |
| Open | 2.62 |
| Day High | 2.95 |
| Day Low | 2.5 |
| 52-Week High | 6.37 |
| 52-Week Low | 0 |
| Volume | 2,881 |
| Average Volume | 6,478 |
| Market Cap | 37.58M |
| PE | 3.41 |
| EPS | 0.85 |
| Moving Average 50 Days | 2.1 |
| Moving Average 200 Days | 1.45 |
| Change | 0.6 |
If you invested $1000 in Eagle Pharmaceuticals, Inc. (EGRX) 10 years ago, it would be worth $36.96 as of July 01, 2025 at a share price of $2.9. Whereas If you bought $1000 worth of Eagle Pharmaceuticals, Inc. (EGRX) shares 5 years ago, it would be worth $59.3 as of July 01, 2025 at a share price of $2.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
GlobeNewswire Inc.
Mar 31, 2025 8:00 PM GMT
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has entered into a royalty purchase agreement with an entity that was provided capital by funds
Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
GlobeNewswire Inc.
Mar 21, 2025 8:30 PM GMT
WOODCLIFF LAKE, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its previously disclosed limited
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration
GlobeNewswire Inc.
Nov 15, 2024 10:00 PM GMT
WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has notified The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to file its own For